Borderline Glaucoma, Thin Corneas, Asthma, and a Pregnancy Plan

Privileges are not the binding constraint; the workup is.

• A glaucoma-certified Kentucky optometrist may diagnose and treat open-angle glaucoma, but treatment without a documented risk assessment and baseline data is indefensible either way - treat or observe.
• Risk picture: IOP in the mid-20s with corneas under 505 µm implies higher true pressure; 0.12 of cup asymmetry with inferior thinning; a first-degree relative; high myopia. That is moderate-to-high conversion risk, but two field points and a borderline index are not a glaucomatous defect - they may be early damage or artifact.
• Before any prescription: gonioscopy to confirm the angle is open (also mandatory before relying on a diagnosis of open-angle glaucoma), a full-threshold baseline field, optic nerve imaging or stereoscopic photos, blood pressure, and repeated pressure measurement at a different time of day.
• The insurance-reset pressure is a financial constraint, not a clinical one; it can shape the follow-up interval but must never appear in the chart as the reason for treatment.
• Document the risk calculation, the discussion of observation versus treatment, and the chosen interval. Observation with a 4-month recheck is a defensible plan if the reasoning is written down.

Eliminate the beta blocker; treat the prostaglandin as a discussion, not a default.

• Topical beta blockers (timolol, levobunolol) are the clearest contraindication: even 'cardioselective' topical agents are systemically absorbed and can precipitate bronchospasm in a patient using inhaled beta-agonists and corticosteroids. Do not start one.
• Prostaglandin analogs are the most effective first-line agent for IOP lowering, but pregnancy data are limited and most labeling is category C; for a patient actively trying to conceive, the risk-benefit conversation must be explicit, involve her obstetric clinician, and be documented. Periorbital fat atrophy and iris darkening also deserve mention.
• Alpha agonists cause fatigue and dry mouth and are best avoided in young children; carbonic anhydrase inhibitors warrant caution with sulfonamide sensitivity; pilocarpine is poorly tolerated and not first line.
• A reasonable framing: if she wants to avoid chronic medication through a pregnancy, selective laser trabeculoplasty (if within this clinician's privileges) or referral for laser is worth discussing; otherwise start the agent she and her obstetrician accept and record the discussion.

Set the triggers in advance so the decision is not made in the moment.

• Refer or co-manage for: pressures persistently above the mid-20s despite therapy, progressive rim thinning or new hemorrhage, a reproducible field defect on repeat testing, an angle that gonioscopy shows to be narrow or closed, unreliable fields or a disc that cannot be evaluated, or a need for incisional surgery.
• Structure: a written co-management agreement naming who measures pressure, who images, who renews, and who is accountable for the interval; a records-exchange routine so the specialist sees the actual images and fields, not a summary line; and an explicit statement to the patient of who to call for what.
• Document her stated preferences (she wanted to avoid a specialist visit and out-of-pocket costs) and the counseling that explained why a referral may still be necessary - that record protects both the patient and the clinician.
• Finally, confirm the practice's certification status permits the treatment being undertaken; if the clinician's glaucoma privileges did not cover it, the plan changes to referral from the outset.